和 提取物混合物对 3T3-L1 前体脂肪细胞和高脂肪饮食诱导的小鼠的抗脂肪生成作用。
Antiadipogenic Effects of Mixtures of and Extracts on 3T3-L1 Preadipocytes and High-Fat Diet-Induced Mice.
机构信息
Department of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Korea.
Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon 16499, Korea.
出版信息
Molecules. 2020 May 18;25(10):2350. doi: 10.3390/molecules25102350.
Medicinal plants have been used worldwide as primary alternative healthcare supplements. (CO) and (RF) are traditional medicinal plants applied in East Asia to treat human diseases such as hepatitis, osteoporosis, oxidative stress and allergy. The aim of this study was to examine the anti-obesity effect of CO and RF on preadipocyte 3T3-L1 cells in vitro and high-fat diet (HFD)-induced obesity mice in vivo. Combination treatment of CO and RF in differentiated 3T3-L1 cells inhibited adipocyte differentiation through downregulation of adipogenesis-associated genes such as CCAAT/enhancer-binding protein alpha (), fatty acid binding protein 4 (), peroxisome proliferator-activated receptor gamma ) and sterol regulatory element binding protein (). In vivo animal models showed that a mixture of CO and RF inhibited HFD-induced weight gain, resulting in decreased abdominal visceral fat tissues and fatty hepatocyte deposition. In addition, CO+RF treatment decreased HFD-induced adipogenesis-associated genes in abdominal white fat tissue. These results suggest that administration of a CO and RF mixture prevented adipocyte differentiation and lipid accumulation in preadipocyte cells and HFD-induced body weight in obesity mice. Therefore, combined therapy of CO and RF may be a protective therapeutic agent against obesity.
药用植物作为主要的替代医疗保健品在全球范围内得到应用。CO 和 RF 是应用于东亚的传统药用植物,用于治疗人类疾病,如肝炎、骨质疏松症、氧化应激和过敏。本研究旨在探讨 CO 和 RF 在体外脂肪前体细胞 3T3-L1 细胞和高脂饮食(HFD)诱导肥胖小鼠体内的抗肥胖作用。CO 和 RF 在分化的 3T3-L1 细胞中的联合治疗通过下调脂肪生成相关基因如CCAAT/增强子结合蛋白α()、脂肪酸结合蛋白 4()、过氧化物酶体增殖物激活受体γ()和固醇调节元件结合蛋白()来抑制脂肪细胞分化。体内动物模型表明,CO 和 RF 的混合物抑制 HFD 诱导的体重增加,导致腹部内脏脂肪组织和脂肪性肝细胞沉积减少。此外,CO+RF 处理降低了 HFD 诱导的腹部白色脂肪组织中与脂肪生成相关的基因。这些结果表明,CO 和 RF 混合物的给药可预防肥胖小鼠脂肪前体细胞和 HFD 诱导的体重增加中的脂肪细胞分化和脂质积累。因此,CO 和 RF 的联合治疗可能是一种对抗肥胖的保护性治疗剂。
相似文献
Nutrients. 2020-1-30
引用本文的文献
BMC Complement Med Ther. 2023-6-19
Medicina (Kaunas). 2022-3-23
Life (Basel). 2022-2-17
Animals (Basel). 2021-11-8
Probiotics Antimicrob Proteins. 2022-2
Front Pharmacol. 2021-4-12
本文引用的文献
Nutrients. 2020-1-30
Int J Mol Sci. 2019-2-15
BMC Complement Altern Med. 2019-1-18
Metabolism. 2018-11-29
Adolesc Med State Art Rev. 2017